PL
Peter Lawson Barclays Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
1
IDEAYA Biosciences
IDYA
$2.38B
| $27.17 | $40 |
47%
upside
| Overweight | yesterday |
|
2
Schrodinger
SDGR
$1.41B
| $19.13 | $25 |
31%
upside
| Overweight | 22 days ago |
|
3
Replimune Group
REPL
$494M
| $6.33 | $3 |
53%
downside
| Equal-Weight | 1 month ago |
|
4
Exelixis
EXEL
$10.2B
| $37.90 | $40 |
6%
upside
| Equal-Weight | 1 month ago |
|
5
Iovance Biotherapeutics
IOVA
$905M
| $2.50 | $4 |
60%
upside
| Overweight | 3 months ago |
|
6
Xencor
XNCR
$610M
| $8.55 | $6 |
30%
downside
| Underweight | 4 months ago |
|
7
Kura Oncology
KURA
$713M
| $8.22 | $11 |
34%
upside
| Overweight | 4 months ago |
|
8
Arvinas
ARVN
$574M
| $7.82 | $16 |
105%
upside
| Overweight | 4 months ago |
|
|
BCYC
9
Bicycle Therapeutics
BCYC
$496M
| $7.16 | $15 |
110%
upside
| Overweight | 4 months ago |
|
10
Arcus Biosciences
RCUS
$1.3B
| $12.22 | $14 |
15%
upside
| Overweight | 4 months ago |
|
11
Geron
GERN
$900M
| $1.41 | $4 |
184%
upside
| Overweight | 6 months ago |
|
12
Revolution Medicines
RVMD
$7.57B
| $40.51 | $60 |
48%
upside
| Overweight | 11 months ago |
|
13
Relay Therapeutics
RLAY
$712M
| $4.13 | $17 |
312%
upside
| Overweight | 1 year ago |
|
14
Syndax Pharmaceuticals
SNDX
$1.47B
| $17.05 | $33 |
94%
upside
| Overweight | 1 year ago |
|
15
Immunocore
IMCR
$1.87B
| $37.19 | $66 |
77%
upside
| Overweight | 1 year ago |
|
16
Nurix Therapeutics
NRIX
$758M
| $9.91 | $31 |
213%
upside
| Overweight | 1 year ago |
|
17
Tango Therapeutics
TNGX
$773M
| $6.95 | $13 |
87%
upside
| Overweight | 1 year ago |
|
18
CytomX Therapeutics
CTMX
$374M
| $2.27 | $3.50 |
54%
upside
| Overweight | 3 years ago |
|
19
Illumina
ILMN
$15.6B
| $98.80 | $365 |
269%
upside
| Underweight | 4 years ago |
|
20
Agios Pharmaceuticals
AGIO
$2.09B
| $36.05 | $46 |
28%
upside
| Overweight | 4 years ago |
|
21
Nektar Therapeutics
NKTR
$763M
| $40.10 | $450 |
1,022%
upside
| Overweight | 5 years ago |
|